Rimegepant

FDA approvals rise 49% in 2023; CRISPR’s gene editing therapy sees light of day

In 2022, when the US Food and Drug Administration (FDA) was reeling under the impact of the pandem

Company Tracker: Pfizer turns to acquisitions as Covid products’ sales nosedive

Over the last five years, a lot has changed for Pfizer Inc, one of the world’s leading pharma

New Drug Approvals by FDA & EMA (Mid-2020 Recap)

In case you thought Covid-19 had slowed down US Food and Drug Administration’s New Drug Approv